Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7022) 7022
Publication (1253) 1253
Book Review (18) 18
Conference Proceeding (16) 16
Dissertation (14) 14
Book Chapter (8) 8
Magazine Article (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cd8-positive t-lymphocytes - immunology (5680) 5680
animals (4435) 4435
humans (3826) 3826
mice (3705) 3705
immunology (3499) 3499
index medicus (3481) 3481
female (2625) 2625
cd4-positive t-lymphocytes - immunology (2436) 2436
male (2212) 2212
mice, inbred c57bl (2013) 2013
transplantation (1702) 1702
t cells (1656) 1656
lymphocytes (1564) 1564
cd8-positive t-lymphocytes - metabolism (1406) 1406
adult (1150) 1150
dendritic cells (1136) 1136
mice, inbred balb c (1092) 1092
middle aged (1054) 1054
flow cytometry (1047) 1047
expression (1011) 1011
in-vivo (979) 979
cd8-positive t-lymphocytes - cytology (895) 895
immunotherapy (885) 885
mice, knockout (839) 839
mice, transgenic (826) 826
adoptive transfer (825) 825
hematology (825) 825
cells, cultured (812) 812
oncology (805) 805
surgery (756) 756
transplantation, homologous (732) 732
article (713) 713
dendritic cells - immunology (707) 707
cd8-positive t-lymphocytes - pathology (699) 699
medicine, research & experimental (698) 698
cd8-positive t-lymphocytes - transplantation (686) 686
t-cells (673) 673
lymphocyte activation (670) 670
activation (646) 646
t-lymphocyte subsets - immunology (628) 628
cancer (626) 626
responses (622) 622
lymphocytes t (609) 609
cd4-positive t-lymphocytes - metabolism (601) 601
cd8 antigen (601) 601
cd8-positive t-lymphocytes - drug effects (587) 587
graft rejection - immunology (581) 581
aged (574) 574
abridged index medicus (566) 566
cell biology (565) 565
t-lymphocytes - immunology (564) 564
immunity (555) 555
antigen (550) 550
antigens (547) 547
lymphocyte activation - immunology (544) 544
cell proliferation (539) 539
analysis (522) 522
disease models, animal (513) 513
infection (490) 490
t-lymphocytes, regulatory - immunology (482) 482
cell line, tumor (477) 477
t-lymphocytes, cytotoxic - immunology (460) 460
time factors (456) 456
tolerance (456) 456
apoptosis (454) 454
research (448) 448
research article (442) 442
immunologic memory (436) 436
cd8 (431) 431
cytokines (427) 427
neoplasm transplantation (425) 425
health aspects (423) 423
killer cells, natural - immunology (421) 421
induction (415) 415
graft vs host disease - immunology (405) 405
lymphocyte count (401) 401
t cell receptors (389) 389
cd4-positive t-lymphocytes - cytology (385) 385
interferon-gamma - metabolism (382) 382
rats (382) 382
multidisciplinary sciences (379) 379
immunophenotyping (373) 373
phenotype (373) 373
disease (370) 370
ifn-gamma (370) 370
medicine (370) 370
immune system (365) 365
memory (360) 360
immune response (356) 356
bone-marrow-transplantation (350) 350
spleen - immunology (349) 349
cytotoxicity, immunologic (347) 347
differentiation (343) 343
adolescent (327) 327
cd4 (323) 323
cd4 antigen (323) 323
interferon-gamma (323) 323
cd8-positive t-lymphocytes - virology (320) 320
versus-host-disease (319) 319
cd8 t-cells (316) 316
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6964) 6964
Chinese (38) 38
Japanese (9) 9
French (8) 8
German (2) 2
Spanish (2) 2
Croatian (1) 1
Hungarian (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
by Gardner, RA and Finney, O and Annesley, C and Brakke, H and Summers, C and Leger, K and Bleakley, M and Brown, C and Mgebroff, S and Kelly-Spratt, KS and Hoglund, V and Lindgren, C and Oron, AP and Li, D and Riddell, SR and Park, JR and Jensen, MC
BLOOD, ISSN 0006-4971, 06/2017, Volume 129, Issue 25, pp. 3322 - 3331
Transitioning CD19-directed chimeric antigen receptor (CAR) T cells from early-phase trials in relapsed patients to a viable therapeutic approach with... 
CD8(+) | B-CELL | HEMATOLOGY | ANTIGEN RECEPTORS | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | CD8-Positive T-Lymphocytes - transplantation | Humans | Neoplasm Recurrence, Local - therapy | Child, Preschool | Infant | Male | Remission Induction | CD4-Positive T-Lymphocytes - immunology | Neoplasm Recurrence, Local - immunology | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | CD4-Positive T-Lymphocytes - transplantation | Adolescent | Adult | Female | Receptors, Antigen, T-Cell - immunology | CD8-Positive T-Lymphocytes - immunology | Child | Antigens, CD19 - immunology | 100 | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
by Klug, Felix and Prakash, Hridayesh and Huber, Peter E and Seibel, Tobias and Bender, Noemi and Halama, Niels and Pfirschke, Christina and Voss, Ralf Holger and Timke, Carmen and Umansky, Ludmila and Klapproth, Kay and Schäkel, Knut and Garbi, Natalio and Jäger, Dirk and Weitz, Jürgen and Schmitz-Winnenthal, Hubertus and Hämmerling, Günter J and Beckhove, Philipp
Cancer Cell, ISSN 1535-6108, 11/2013, Volume 24, Issue 5, pp. 589 - 602
Inefficient T cell migration is a major limitation of cancer immunotherapy. Targeted activation of the tumor microenvironment may overcome this barrier. We... 
DESTRUCTION | MICROENVIRONMENT | ANGIOGENESIS | ONCOLOGY | ENDOTHELIUM | INFLAMMATION | PANCREATIC-CANCER | BONE-MARROW | TUMOR-ASSOCIATED MACROPHAGES | TUMORIGENESIS | INFILTRATION | CELL BIOLOGY | Neoplasm Transplantation | Tumor Escape | CD8-Positive T-Lymphocytes - transplantation | Humans | Pancreatic Neoplasms - blood supply | Vaccination | CD4-Positive T-Lymphocytes - immunology | Insulinoma - blood supply | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Inflammation Mediators - metabolism | Female | Macrophages - radiation effects | Radiotherapy, Adjuvant | Insulinoma - immunology | Cell Differentiation - radiation effects | Macrophages - physiology | Radiotherapy Dosage | Immunotherapy, Adoptive | Cells, Cultured | Mice, Transgenic | Mice, SCID | Insulinoma - therapy | Mice, Inbred C3H | Phenotype | Animals | CD4-Positive T-Lymphocytes - transplantation | Melanoma - immunology | Pancreatic Neoplasms - immunology | Mice, Inbred NOD | Mice | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Nitric Oxide Synthase Type II - metabolism | Pancreatic Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
by He, Ran and Hou, Shiyue and Liu, Cheng and Zhang, Anli and Bai, Qiang and Han, Miao and Yang, Yu and Wei, Gang and Shen, Ting and Yang, Xinxin and Xu, Lifan and Chen, Xiangyu and Hao, Yaxing and Wang, Pengcheng and Zhu, Chuhong and Ou, Juanjuan and Liang, Houjie and Ni, Ting and Zhang, Xiaoyan and Zhou, Xinyuan and Deng, Kai and Chen, Yaokai and Luo, Yadong and Xu, Jianqing and Qi, Hai and Wu, Yuzhang and Ye, Lilin
Nature, ISSN 0028-0836, 2016, Volume 537, Issue 7620, pp. 412 - 416
During chronic viral infection, virus-specific CD8(+) T cells become exhausted, exhibit poor effector function and lose memory potential(1-4). However,... 
HIV-1 | VIRUS | REPLICATION | FOLLICLES | MULTIDISCIPLINARY SCIENCES | IN-VIVO | TRANSCRIPTION | DIFFERENTIATION | BLOCKADE | EXHAUSTION | SELF-TOLERANCE | Lymphocytic choriomeningitis virus - immunology | T-Lymphocyte Subsets - immunology | CD8-Positive T-Lymphocytes - cytology | T-Lymphocyte Subsets - cytology | CD8-Positive T-Lymphocytes - transplantation | Germinal Center - immunology | Humans | Male | Adoptive Transfer | Lymphocytic Choriomeningitis - immunology | HIV Infections - immunology | Basic Helix-Loop-Helix Transcription Factors - metabolism | CD8-Positive T-Lymphocytes - metabolism | Female | Cell Differentiation | Germinal Center - cytology | Lymphocytic Choriomeningitis - virology | Receptors, CXCR5 - metabolism | Signal Transduction | HIV Infections - virology | Receptors, CXCR5 - deficiency | Virus Replication - immunology | T-Lymphocyte Subsets - transplantation | Inhibitor of Differentiation Protein 2 - metabolism | Viral Load - immunology | Lymphocytic choriomeningitis virus - growth & development | Animals | B-Lymphocytes - immunology | T-Lymphocyte Subsets - metabolism | Mice | CD8-Positive T-Lymphocytes - immunology | Chronic Disease | Virus diseases | Physiological aspects | T cells | Health aspects | Membrane proteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
by Pauken, Kristen E and Sammons, Morgan A and Odorizzi, Pamela M and Manne, Sasikanth and Godec, Jernej and Khan, Omar and Drake, Adam M and Chen, Zeyu and Sen, Debattama R and Kurachi, Makoto and Barnitz, R. Anthony and Bartman, Caroline and Bengsch, Bertram and Huang, Alexander C and Schenkel, Jason M and Vahedi, Golnaz and Haining, W. Nicholas and Berger, Shelley L and Wherry, E. John
Science, ISSN 0036-8075, 12/2016, Volume 354, Issue 6316, pp. 1160 - 1165
Blocking Programmed Death-1 (PD-1) can reinvigorate exhausted CD8 Tcells (TEX) andimprove control of chronic infections and cancer. However, whether blocking... 
RESPONSES | THERAPY | MEMORY | CHROMATIN | MULTIDISCIPLINARY SCIENCES | INHIBITORY RECEPTOR PD-1 | CHRONIC VIRAL-INFECTION | EXPRESSION | CANCER | CHECKPOINT BLOCKADE | ANTIGEN | CD8-Positive T-Lymphocytes - transplantation | Epigenesis, Genetic | Mice, Inbred C57BL | Gene Regulatory Networks | B7-H1 Antigen - genetics | Cellular Reprogramming - immunology | Animals | B7-H1 Antigen - antagonists & inhibitors | Immunotherapy | Female | Transcription, Genetic | Mice | CD8-Positive T-Lymphocytes - immunology | Cellular Reprogramming - genetics | Cell Lineage - genetics | Immunologic Memory - genetics | Interleukin-7 - metabolism | Cellular proteins | Epigenetic inheritance | Genetic aspects | Immune response | T cells | Health aspects | Epigenetics | Cellular biology | Lymphocytes | Antigens | Control | Rewiring | Exhaustion | Effectors | Durability | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
by Spranger, Stefani and Dai, Daisy and Horton, Brendan and Gajewski, Thomas F
Cancer Cell, ISSN 1535-6108, 05/2017, Volume 31, Issue 5, pp. 711 - 723.e4
Effector T cells have the capability of recognizing and killing cancer cells. However, whether tumors can become immune resistant through exclusion of effector... 
T cell-inflamed tumor microenvironment | non-T cell-inflamed tumor microenvironment | immunotherapy resistance | immune escape | adoptive T cell transfer | METASTATIC MELANOMA | RESPONSES | IMMUNITY | MECHANISM | ONCOLOGY | CANCER REGRESSION | REJECTION | ANTIGENS | MICE | BLOCKADE | EXPRESSION | CELL BIOLOGY | Chemotaxis, Leukocyte | Tumor Escape | Basic-Leucine Zipper Transcription Factors - metabolism | Cell Proliferation | Dendritic Cells - immunology | Tumor Microenvironment | T-Lymphocytes - transplantation | Antigens, CD - metabolism | Repressor Proteins - deficiency | T-Lymphocytes - metabolism | Time Factors | Basic-Leucine Zipper Transcription Factors - deficiency | CD8-Positive T-Lymphocytes - metabolism | Dendritic Cells - metabolism | Repressor Proteins - metabolism | Melanoma - metabolism | Skin Neoplasms - pathology | Immunotherapy, Adoptive - methods | Signal Transduction | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Repressor Proteins - genetics | Genotype | Integrin alpha Chains - metabolism | Basic-Leucine Zipper Transcription Factors - genetics | Melanoma - pathology | Tumor Burden | beta Catenin - metabolism | Mice, Knockout | Skin Neoplasms - metabolism | Phenotype | Animals | Melanoma - immunology | Chemokine CXCL9 - metabolism | Cell Line, Tumor | Immunologic Memory | T-Lymphocytes - immunology | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Chemokine CXCL10 - metabolism | Dendritic cells | T cells | Cancer | Immunotherapy | Adoptive T cell transfer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The epigenetic landscape of T cell exhaustion
by Sen, Debattama R and Kaminski, James and Barnitz, R. Anthony and Kurachi, Makoto and Gerdemann, Ulrike and Yates, Kathleen B and Tsao, Hsiao-Wei and Godec, Jernej and LaFleur, Martin W and Brown, Flavian D and Tonnerre, Pierre and Chung, Raymond T and Tully, Damien C and Allen, Todd M and Frahm, Nicole and Lauer, Georg M and Wherry, E. John and Yosef, Nir and Haining, W. Nicholas
Science, ISSN 0036-8075, 12/2016, Volume 354, Issue 6316, pp. 1165 - 1169
Exhausted T cells in cancer and chronic viral infection express distinctive patterns of genes, including sustained expression of programmed cell death protein... 
REGULATORY DNA | CHROMATIN | CHRONIC VIRAL-INFECTION | MULTIDISCIPLINARY SCIENCES | CD8-Positive T-Lymphocytes - transplantation | Epigenesis, Genetic | Humans | Mice, Inbred C57BL | Hepatitis C, Chronic - therapy | Lymphocytic Choriomeningitis - therapy | B7-H1 Antigen - genetics | Gene Editing | T-Box Domain Proteins - metabolism | SOXB1 Transcription Factors - metabolism | Animals | B7-H1 Antigen - antagonists & inhibitors | Enhancer Elements, Genetic | Chromatin - immunology | Immunotherapy | HIV Infections - therapy | Transcription, Genetic | Mice | CD8-Positive T-Lymphocytes - immunology | Chronic Disease | Cell Lineage - genetics | Immunologic Memory - genetics | Disease Models, Animal | Epigenetic inheritance | Chromatin | Genetic research | Genetic aspects | Research | T cells | Properties | Gene expression | Health aspects | Epigenetics | Genotype & phenotype | Infections | Lymphocytes | Cancer | Landscapes | Genes | Modules | Editing | Genomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Immune-mediated antitumor effect by type 2 diabetes drug, metformin
by Shingo Eikawa and Mikako Nishida and Shusaku Mizukami and Chihiro Yamazaki and Eiichi Nakayama and Heiichiro Udono
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2015, Volume 112, Issue 6, pp. 1809 - 1814
Metformin, a prescribed drug for type 2 diabetes, has been reported to have anti-cancer effects; however, the underlying mechanism is poorly understood. Here... 
Antitumor immunity | Multifunctionality | Tumor microenvironment | CD8T cells | Immune exhaustion | MULTIDISCIPLINARY SCIENCES | RISK | antitumor immunity | T-CELL EXHAUSTION | CANCER STEM-CELLS | TUMOR REJECTION | MEMORY | INSULIN ANALOGS | IMMUNOTHERAPY | IN-VIVO | immune exhaustion | tumor microenvironment | DIFFERENTIATION | TIM-3 | multifunctionality | Antineoplastic Agents - immunology | Apoptosis - drug effects | CD8-Positive T-Lymphocytes - transplantation | AMP-Activated Protein Kinases - antagonists & inhibitors | Metformin - pharmacology | Mice, Inbred C57BL | Lymphocytes, Tumor-Infiltrating - transplantation | Adoptive Transfer | Lymphocytes, Tumor-Infiltrating - drug effects | Mice, SCID | Neoplasms - drug therapy | Cell Movement - immunology | Tumor Microenvironment - immunology | Animals | Apoptosis - immunology | CD8-Positive T-Lymphocytes - drug effects | Metformin - immunology | Antineoplastic Agents - pharmacology | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Cytokines - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Type 2 diabetes | Prevention | Drug interactions | Dosage and administration | Metformin | Drug therapy | Observations | Tumors | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text CD8+ enriched "Young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
by Dudley, Mark E and Gross, Colin A and Langhan, Michelle M and Garcia, Marcos R and Sherry, Richard M and Yang, James C and Phan, Giao Q and Kammula, Udai S and Hughes, Marybeth S and Citrin, Deborah E and Restifo, Nicholas P and Wunderlich, John R and Prieto, Peter A and Hong, Jenny J and Langan, Russell C and Zlott, Daniel A and Morton, Kathleen E and White, Donald E and Laurencot, Carolyn M and Rosenberg, Steven A
Clinical Cancer Research, ISSN 1078-0432, 12/2010, Volume 16, Issue 24, pp. 6122 - 6131
Purpose: Tumor-infiltrating lymphocytes (TIL) and interleukin (IL)-2 administered following lymphodepletion can cause the durable complete regression of bulky... 
SURVIVAL | ADOPTIVE TRANSFER | ONCOLOGY | CD8-T-CELL MEMORY | IMMUNOTHERAPY | AUTOIMMUNITY | CD4-T-CELL HELP | PERSISTENCE | CANCER | CD8(+) T-CELLS | TRANSFER THERAPY | Lymphocytes, Tumor-Infiltrating - cytology | CD8-Positive T-Lymphocytes - cytology | Immunotherapy, Adoptive - methods | CD8-Positive T-Lymphocytes - transplantation | Humans | Middle Aged | Cells, Cultured | Lymphocytes, Tumor-Infiltrating - transplantation | Male | Combined Modality Therapy | Cytotoxicity, Immunologic - physiology | Melanoma - pathology | Neoplasm Metastasis | Melanoma - immunology | Aged, 80 and over | Lymphocyte Count | Adult | Female | Aged | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Lymphocytes, Tumor-Infiltrating - immunology | Tumor Burden - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
by Berger, Carolina and Jensen, Michael C and Lansdorp, Peter M and Gough, Mike and Elliott, Carole and Riddell, Stanley R
Journal of Clinical Investigation, ISSN 0021-9738, 01/2008, Volume 118, Issue 1, pp. 294 - 305
The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T... 
MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | IMMUNITY | TCR GENE-TRANSFER | IMMUNOTHERAPY | IN-VIVO PERSISTENCE | SUBSETS | EXPRESSION | TRANSFER THERAPY | TELOMERE LENGTH | LYMPHOCYTES | Macaca nemestrina | Neoplasms - therapy | Animals | Time Factors | CD8-Positive T-Lymphocytes - transplantation | Neoplasms - immunology | Cells, Cultured | Immunologic Memory | Adoptive Transfer | Cell Culture Techniques | CD8-Positive T-Lymphocytes - immunology | Cell Survival - immunology | Infection | Care and treatment | Research | T cells | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice
by Elong Ngono, Annie and Vizcarra, Edward A and Tang, William W and Sheets, Nicholas and Joo, Yunichel and Kim, Kenneth and Gorman, Matthew J and Diamond, Michael S and Shresta, Sujan
Cell Host & Microbe, ISSN 1931-3128, 01/2017, Volume 21, Issue 1, pp. 35 - 46
CD8 T cells may play a dual role in protection against and pathogenesis of flaviviruses, including Zika virus (ZIKV). We evaluated the CD8 T cell response in... 
LysMCre+IFNARfl/fl | CD8+ T cell | peptide | Zika virus | mouse model | epitope | LysMCre | CD8 | IFNAR | T cell | ANTIBODIES | WESTERN-HEMISPHERE | DENGUE HEMORRHAGIC-FEVER | MICROBIOLOGY | SEXUAL TRANSMISSION | MOUSE MODELS | PATHOGENESIS | INTERFERON | REPLICATION | VIROLOGY | PROTECTIVE ROLE | DISEASE | PARASITOLOGY | Zika Virus - immunology | CD8-Positive T-Lymphocytes - transplantation | Mice, Inbred C57BL | Adoptive Transfer | Receptor, Interferon alpha-beta - antagonists & inhibitors | Mice, Knockout | Zika Virus Infection - virology | Animals | Receptor, Interferon alpha-beta - immunology | Antibodies, Blocking - immunology | Zika Virus Infection - immunology | Mice | Receptor, Interferon alpha-beta - genetics | Epitopes, T-Lymphocyte - immunology | CD8-Positive T-Lymphocytes - immunology | Disease Models, Animal | LysMCre+IFNARfl | CD8+ T cell
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
by Nagaraj, Srinivas and Schrum, Adam G and Cho, Hyun-Il and Celis, Esteban and Gabrilovich, Dmitry I
The Journal of Immunology, ISSN 0022-1767, 03/2010, Volume 184, Issue 6, pp. 3106 - 3116
Ag-specific T cell tolerance plays a critical role in tumor escape. Recent studies implicated myeloid-derived suppressor cells (MDSCs) in the induction of... 
IMMUNE-RESPONSE | SIGNAL-TRANSDUCTION MOLECULES | OXIDATIVE-STRESS | TUMOR-BEARING MICE | DOWN-REGULATION | BREAST-TUMORS | RECEPTOR COMPLEX | ZETA-CHAIN | IMMUNOLOGY | CANCER | ANTIGEN | CD8-Positive T-Lymphocytes - pathology | CD8-Positive T-Lymphocytes - transplantation | Transplantation Tolerance - genetics | Adoptive Transfer | Neoplasms, Experimental - pathology | Leukemia, Experimental - immunology | Signal Transduction - immunology | Myeloid Cells - immunology | Neoplasms, Experimental - immunology | Neoplasms, Experimental - genetics | Female | Epitopes, T-Lymphocyte - immunology | Tumor Cells, Cultured | Transplantation Tolerance - immunology | Leukemia, Experimental - genetics | Leukemia, Experimental - pathology | Mice, Inbred C57BL | Antigen Presentation - genetics | Mice, Transgenic | Signal Transduction - genetics | Antigen Presentation - immunology | Genes, T-Cell Receptor beta - immunology | Animals | Cell Line, Tumor | Myeloid Cells - transplantation | Mice | Mice, Inbred BALB C | Myeloid Cells - pathology | CD8-Positive T-Lymphocytes - immunology | Epitopes, T-Lymphocyte - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
by Rossi, John and Paczkowski, Patrick and Shen, Yueh-Wei and Morse, Kevin and Flynn, Brianna and Kaiser, Alaina and Ng, Colin and Gallatin, Kyle and Cain, Tom and Fan, Rong and Mackay, Sean and Heath, James R and Rosenberg, Steven A and Kochenderfer, James N and Zhou, Jing and Bot, Adrian
Blood, ISSN 0006-4971, 08/2018, Volume 132, Issue 8, pp. 804 - 814
After treatment with chimeric antigen receptor (CAR) T cells, interleukin-15 (IL-15) elevation and CAR T-cell expansion are associated with non-Hodgkin... 
LYMPHOMA | HEMATOLOGY | IMMUNOTHERAPY | VACCINE DESIGN | CANCER-THERAPY | Lymphoma, Non-Hodgkin - immunology | CD8-Positive T-Lymphocytes - pathology | CD8-Positive T-Lymphocytes - transplantation | Humans | Middle Aged | Receptors, Antigen, T-Cell - therapeutic use | Male | Adoptive Transfer | CD4-Positive T-Lymphocytes - pathology | Lymphoma, Non-Hodgkin - pathology | CD4-Positive T-Lymphocytes - immunology | Receptors, Chimeric Antigen - therapeutic use | CD4-Positive T-Lymphocytes - transplantation | Lymphoma, Non-Hodgkin - therapy | K562 Cells | Adult | Female | Aged | CD8-Positive T-Lymphocytes - immunology | Cytokines - immunology | Index Medicus | Abridged Index Medicus | Immunobiology and Immunotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
by Mark E. Dudley and Colin A. Gross and Robert P.T. Somerville and Young Hong and Nicholas P. Schaub and Shannon F. Rosati and Donald E. White and Debbie Nathan and Nicholas P. Restifo and Seth M. Steinberg and John R. Wunderlich and Udai S. Kammula and Richard M. Sherry and James C. Yang and Giao Q. Phan and Marybeth S. Hughes and Carolyn M. Laurencot and Steven A. Rosenberg
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2152 - 2159
Purpose Adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocytes (TILs) and high-dose interleukin-2 (IL-2) administered to lymphodepleted... 
REGRESSION | METASTATIC MELANOMA | RAPID EXPANSION | RECOGNITION | EFFICACY | ONCOLOGY | REGULATORY T-CELLS | TRANSFER IMMUNOTHERAPY | CANCER | CULTURES | STANDARD | CD8-Positive T-Lymphocytes - pathology | Prospective Studies | CD8-Positive T-Lymphocytes - transplantation | Humans | Middle Aged | Male | Young Adult | Interleukin-2 - administration & dosage | Adult | Female | Tumor Cells, Cultured | Child | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Lymphocytes, Tumor-Infiltrating - transplantation | Lymphocytes, Tumor-Infiltrating - drug effects | Lymphocytes, Tumor-Infiltrating - pathology | Melanoma - immunology | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Adolescent | Aged | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | Original Reports | Mela7 | To6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights